← Back to headlines
Nanyang Biologics Advances $1.5 Billion Nasdaq Listing Plan
Nanyang Biologics is moving forward with its plan for a $1.5 billion Nasdaq listing. This significant step indicates the company's ambition to expand its presence in the global financial markets.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance
24m ago
TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe
28m ago
Analysts Downgrade Qifu Technology and Lower Intuit Price Targets on Sector Headwinds
31m ago
Two Airport Staff Die of Malaria at Frankfurt Airport
37m ago